Amgen (AMGN) stock forecast for 2024. Forecast tables and graphs.

Amgen (AMGN) stock forecast for 2024

The forecast has been updated: August 4, 2021 9:24


Amgen stock price online today

Analyst Target Price

254.96

Dividend Date

08.06.2021

Ex Dividend Date

14.05.2021

Last Split Factor

2:1

Last Split Date

22.11.1999

Should you buy or sell Amgen stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Amgen stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $254.96 target price for Amgen stock stock.

Today 200 Day Moving Average is the support level (243.28 $).

50 Day Moving Average is the support level (243.45 $).




AMGN Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 356.48 341.93 389.41 12.19 %
Feb 329.10 316.07 350.82 9.91 %
Mar 329.49 308.93 337.40 8.44 %
Apr 365.08 355.44 388.74 8.56 %
May 347.12 324.62 366.69 11.47 %
Jun 364.20 354.58 389.98 9.08 %
Jul 358.51 327.54 383.47 14.58 %
Aug 353.35 330.88 363.95 9.09 %
Sep 384.73 350.56 412.43 15.00 %
Oct 414.28 380.47 435.16 12.57 %
Nov 392.90 382.53 426.37 10.28 %
Dec 358.48 329.23 381.28 13.65 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Amgen stock.


Amgen overview

Amgen Address

ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US

Market Capitalization

139 513 201 000 $

EBITDA

12 486 000 000

PE Ratio

20.11

PEG Ratio

1.771

Dividend Per Share

6.56

Dividend Yield

0.0274

EPS

12.07

Quarterly Earnings Growth YOY

-0.078

Quarterly Revenue Growth YOY

-0.042

Trailing PE

20.11

Forward PE

14.68

EV To Revenue

6.39

EV To EBITDA

12.65

52 Week High

272.73

52 Week Low

205.87

50 Day Moving Average

243.45

200 Day Moving Average

243.28

Shares Outstanding

574554000

Shares Float

573462000

Shares Short Prior Month

9342600

Short Ratio

4.42

Percent Insiders

0.194

Percent Institutions

77.86

Amgen stock forecast for this year


Amgen stock forecast for Jan 2024.
Estimated Average Forecasted Amgen Price: 356.48. Negative monthly dynamics of the instrument is expected with 12.193% volatility is expected.

Pessimistic forecast: 341.93

Optimistic: 389.41


Amgen stock forecast for Feb 2024.
Estimated Average Forecasted Amgen Price: 329.10. Negative monthly dynamics of the instrument is expected with 9.906% volatility is expected.

Pessimistic forecast: 316.07

Optimistic: 350.82


Amgen stock forecast for Mar 2024.
Estimated Average Forecasted Amgen Price: 329.49. Positive monthly dynamics of the instrument is expected with 8.437% volatility is expected.

Pessimistic forecast: 308.93

Optimistic: 337.40


Amgen stock forecast for Apr 2024.
Estimated Average Forecasted Amgen Price: 365.08. Positive monthly dynamics of the instrument is expected with 8.565% volatility is expected.

Pessimistic forecast: 355.44

Optimistic: 388.74


Amgen stock forecast for May 2024.
Estimated Average Forecasted Amgen Price: 347.12. Negative monthly dynamics of the instrument is expected with 11.473% volatility is expected.

Pessimistic forecast: 324.62

Optimistic: 366.69


Amgen stock forecast for Jun 2024.
Estimated Average Forecasted Amgen Price: 364.20. Positive monthly dynamics of the instrument is expected with 9.077% volatility is expected.

Pessimistic forecast: 354.58

Optimistic: 389.98


Amgen stock forecast for Jul 2024.
Estimated Average Forecasted Amgen Price: 358.51. Negative monthly dynamics of the instrument is expected with 14.585% volatility is expected.

Pessimistic forecast: 327.54

Optimistic: 383.47


Amgen stock forecast for Aug 2024.
Estimated Average Forecasted Amgen Price: 353.35. Negative monthly dynamics of the instrument is expected with 9.087% volatility is expected.

Pessimistic forecast: 330.88

Optimistic: 363.95


Amgen stock forecast for Sep 2024.
Estimated Average Forecasted Amgen Price: 384.73. Positive monthly dynamics of the instrument is expected with 15.000% volatility is expected.

Pessimistic forecast: 350.56

Optimistic: 412.43


Amgen stock forecast for Oct 2024.
Estimated Average Forecasted Amgen Price: 414.28. Positive monthly dynamics of the instrument is expected with 12.567% volatility is expected.

Pessimistic forecast: 380.47

Optimistic: 435.16


Amgen stock forecast for Nov 2024.
Estimated Average Forecasted Amgen Price: 392.90. Negative monthly dynamics of the instrument is expected with 10.284% volatility is expected.

Pessimistic forecast: 382.53

Optimistic: 426.37


Amgen stock forecast for Dec 2024.
Estimated Average Forecasted Amgen Price: 358.48. Negative monthly dynamics of the instrument is expected with 13.652% volatility is expected.

Pessimistic forecast: 329.23

Optimistic: 381.28



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 121.57 (04.08.2021) -0.45 %
AbbVie Inc.
ABBV 115.08 (04.08.2021) -1.01 %
Aeterna Zentaris Inc.
AEZS 0.7001 (04.08.2021) -1.86 %
Allakos Inc.
ALLK 79.93 (04.08.2021) 2.49 %
Allogene Therapeutics, Inc.
ALLO 22.13 (04.08.2021) 0.91 %
Amgen Inc.
AMGN 228.31 (04.08.2021) -6.46 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 12.4 (04.08.2021) -1.51 %
Aurora Cannabis Inc.
ACB 6.93 (04.08.2021) -3.62 %
Becton Dickinson and Company
BDX 254.74 (04.08.2021) -0.40 %
Biogen Inc.
BIIB 338.1 (04.08.2021) 0.03 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 123.36 (04.08.2021) 3.86 %
BioNTech SE
BNTX 414.44 (04.08.2021) 17.80 %
bluebird bio, Inc.
BLUE 25 (04.08.2021) -0.44 %
Boston Scientific Corp.
BSX 44.26 (04.08.2021) -2.81 %
Bristol-Myers Squibb Company
BMY 68.49 (04.08.2021) -1.18 %
Canopy Growth Corp.
CGC 18.28 (04.08.2021) -2.61 %
Castle Biosciences, Inc.
CSTL 69.19 (04.08.2021) -1.68 %
Eli Lilly and Company
LLY 262.47 (04.08.2021) 2.53 %
Emergent BioSolutions Inc.
EBS 62.04 (04.08.2021) -2.11 %
Exelixis, Inc.
EXEL 16.79 (04.08.2021) -1.06 %
G1 Therapeutics, Inc.
GTHX 16.72 (04.08.2021) -0.59 %
Gilead Sciences, Inc.
GILD 69.24 (04.08.2021) -0.84 %
GlaxoSmithKline plc
GSK 40.5 (04.08.2021) -0.34 %
GoodRx Holdings, Inc.
GDRX 31.78 (04.08.2021) 0.44 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.34 (04.08.2021) -0.78 %
Inovio Pharmaceuticals, Inc.
INO 8.76 (04.08.2021) 1.74 %
Johnson & Johnson
JNJ 173.36 (04.08.2021) -0.59 %
Medtronic plc.
MDT 128.38 (04.08.2021) -2.34 %
Merck & Co., Inc.
MRK 75.48 (04.08.2021) -1.22 %
Moderna, Inc.
MRNA 419.05 (04.08.2021) 8.42 %
Novartis AG
NVS 91.59 (04.08.2021) -1.21 %
Novavax, Inc.
NVAX 223.81 (04.08.2021) 18.69 %
ObsEva SA
OBSV 2.49 (04.08.2021) -0.40 %
OrganiGram Holdings Inc.
OGI 2.49 (04.08.2021) -3.49 %
Pfizer Inc.
PFE 45.19 (04.08.2021) -1.07 %
Regeneron Pharmaceuticals, Inc.
REGN 580.95 (04.08.2021) -0.95 %
Sanofi
SNY 49.88 (04.08.2021) -3.15 %
Schrodinger, Inc.
SDGR 68.43 (04.08.2021) 3.06 %
Senseonics Holdings, Inc.
SENS 3.03 (04.08.2021) -1.94 %
Sorrento Therapeutics, Inc.
SRNE 8.23 (04.08.2021) 0.49 %
Stryker Corp.
SYK 262.58 (04.08.2021) -2.03 %
Sundial Growers Inc.
SNDL 0.7811 (04.08.2021) -4.21 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10 (04.08.2021) 0.81 %
Thermo Fisher Scientific Inc.
TMO 538.88 (04.08.2021) 0.35 %
Tilray, Inc.
TLRY 13.96 (04.08.2021) -2.04 %
UnitedHealth Group, Inc.
UNH 421.54 (04.08.2021) -0.09 %
Veeva Systems Inc.
VEEV 340.98 (04.08.2021) 0.87 %
Zomedica Corp.
ZOM 0.578 (04.08.2021) -4.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.33 (04.08.2021) -2.48 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.